Instil Bio (TIL)
(Real Time Quote from BATS)
$25.28 USD
-1.18 (-4.46%)
Updated Nov 6, 2024 03:12 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Instil Bio, Inc. (TIL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$103.67 | $180.00 | $11.00 | 291.80% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Instil Bio, Inc. comes to $103.67. The forecasts range from a low of $11.00 to a high of $180.00. The average price target represents an increase of 291.8% from the last closing price of $26.46.
Analyst Price Targets (3 )
Broker Rating
Instil Bio, Inc. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on three recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 1.67 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/4/2024 | JMP Securities | Reni Benjamin | Not Available | Hold |
9/16/2024 | Robert W. Baird & Co. | Jack K Allen | Strong Buy | Strong Buy |
8/5/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
4/12/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 4 |
Average Target Price | $103.67 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 95 of 252 |
Current Quarter EPS Est: | -2.08 |
TIL FAQs
Instil Bio, Inc. (TIL) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Instil Bio, Inc. (TIL) is $103.67. The current on short-term price targets is based on 2 reports.
The forecasts for Instil Bio, Inc. (TIL) range from a low of $11 to a high of $180. The average price target represents a increase of $291.80 from the last closing price of $26.46.
The current UPSIDE for Instil Bio, Inc. (TIL) is 291.80%
Based on short-term price targets offered by three analysts, the average price target for Instil Bio, Inc. comes to $103.67. The forecasts range from a low of $11.00 to a high of $180.00. The average price target represents an increase of 291.8% from the last closing price of $26.46.